This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.
Company Profile:
Morphic Holding, Inc.
Market Cap (USD):
$1.59 B
(July 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Celldex Therapeutics, Inc.
Market Cap (USD):
$1.59 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Vir Biotechnology, Inc.
Market Cap (USD):
$1.54 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Novavax, Inc.
Market Cap (USD):
$1.53 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Viridian Therapeutics, Inc.
Market Cap (USD):
$1.51 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Zogenix, Inc.
Market Cap (USD):
$1.49 B
(March 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Dyne Therapeutics, Inc.
Market Cap (USD):
$1.48 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Xencor, Inc.
Market Cap (USD):
$1.43 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Nurix Therapeutics, Inc.
Market Cap (USD):
$1.41 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Longboard Pharmaceuticals, Inc.
Market Cap (USD):
$1.36 B
(July 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Ardelyx, Inc.
Market Cap (USD):
$1.31 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Praxis Precision Medicines, Inc.
Market Cap (USD):
$1.30 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Day One Biopharmaceuticals, Inc.
Market Cap (USD):
$1.26 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Ocular Therapeutix, Inc.
Market Cap (USD):
$1.25 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Arvinas, Inc.
Market Cap (USD):
$1.24 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Syndax Pharmaceuticals, Inc.
Market Cap (USD):
$1.23 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Liquidia Corporation
Market Cap (USD):
$1.22 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Arcutis Biotherapeutics, Inc.
Market Cap (USD):
$1.21 B
(July 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Arcus Biosciences, Inc.
Market Cap (USD):
$1.20 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Adaptive Biotechnologies Corporation
Market Cap (USD):
$1.20 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Rocket Pharmaceuticals, Inc.
Market Cap (USD):
$1.18 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Liquidia Corp
Market Cap (USD):
$1.17 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Innoviva, Inc.
Market Cap (USD):
$1.16 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Intellia Therapeutics, Inc.
Market Cap (USD):
$1.15 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Maravai LifeSciences Holdings, Inc.
Market Cap (USD):
$1.13 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Replimune Group, Inc.
Market Cap (USD):
$1.06 B
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Alpine Immune Sciences, Inc.
Market Cap (USD):
$1.03 B
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Forma Therapeutics Holdings, Inc.
Market Cap (USD):
$1.01 B
(Oct. 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Cogent Biosciences, Inc.
Market Cap (USD):
$982.0 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Nuvation Bio, Inc.
Market Cap (USD):
$942.4 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology